NEW YORK – NeoGenomics said late on Wednesday that it has priced a public offering of its common stock and convertible senior notes for a total of $500 million in gross proceeds.
The Fort Myers, Florida-based firm is offering 4,081,632 shares of its common stock at $49.00 per share. It also is offering $300 million aggregate principal amount of its .25 percent convertible senior notes due January 2028 for gross proceeds of $300 million.